KIPPY BODOSKY: Open Payments
NPI 1265950307 · ALBION, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 118 payments from 21 companies in 2025. Trend: 2023 $2,139 · 2024 $2,149 · 2025 $2,105
Food & beverage: $2,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $456 |
| Novo Nordisk Inc | 16 | $299 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $149 |
| PFIZER INC. | 7 | $133 |
| Lilly USA, LLC | 6 | $125 |
| Amgen Inc. | 7 | $117 |
| Exact Sciences Corporation | 3 | $114 |
| Dexcom, Inc. | 6 | $109 |
| SHIELD THERAPEUTICS INC | 6 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
Products named: VRAYLAR, UBRELVY, Ozempic, CAPLYTA, Dexcom G6 Transmitter, ACCRUFER, MOUNJARO, ELIQUIS.
Industry payments across PA — which companies pay providers there.
